Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.006 | 0.3193 | 0.5 |
Plasmodium falciparum | ATP-dependent DNA helicase Q1 | 0.0019 | 0.0632 | 0.5 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.3357 | 1 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0019 | 0.0632 | 0.5 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.3193 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3357 | 0.3357 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.006 | 0.3193 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.001 | 0.0024 | 0.0000000015348 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3357 | 0.3357 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.3357 | 0.2909 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3357 | 0.3357 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0632 | 0.1981 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.3193 | 0.5 |
Trichomonas vaginalis | DNA helicase recq1, putative | 0.0019 | 0.0632 | 0.5 |
Entamoeba histolytica | recQ family DNA helicase | 0.001 | 0.0024 | 0.0381 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.3357 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.3193 | 0.3193 |
Brugia malayi | RNA binding protein | 0.0062 | 0.3357 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0632 | 0.1825 |
Loa Loa (eye worm) | ATP-dependent DNA helicase | 0.0019 | 0.0632 | 0.1825 |
Treponema pallidum | ATP-dependent DNA helicase | 0.001 | 0.0024 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3357 | 0.3357 |
Schistosoma mansoni | DNA helicase recq5 | 0.0019 | 0.0632 | 0.0632 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.006 | 0.3193 | 1 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.3357 | 0.2909 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.3357 | 1 |
Schistosoma mansoni | DNA helicase recq1 | 0.0019 | 0.0632 | 0.0632 |
Schistosoma mansoni | blooms syndrome DNA helicase | 0.001 | 0.0024 | 0.0024 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.006 | 0.3193 | 0.5 |
Plasmodium vivax | ADP-dependent DNA helicase RecQ, putative | 0.001 | 0.0024 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.3357 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.006 | 0.3193 | 0.2733 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.0019 | 0.0632 | 0.1981 |
Trypanosoma cruzi | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0632 | 1 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.3357 | 1 |
Toxoplasma gondii | ATP-dependent DNA helicase, RecQ family protein | 0.001 | 0.0024 | 0.0075 |
Trypanosoma brucei | ATP-dependent DEAD/H DNA helicase recQ, putative | 0.0019 | 0.0632 | 0.5 |
Plasmodium falciparum | ADP-dependent DNA helicase RecQ | 0.0019 | 0.0632 | 0.5 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.006 | 0.3193 | 0.2733 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.3357 | 0.3357 |
Entamoeba histolytica | recQ family helicase, putative | 0.0019 | 0.0632 | 1 |
Giardia lamblia | Sgs1 DNA helicase, putative | 0.0019 | 0.0632 | 0.5 |
Loa Loa (eye worm) | RecQ helicase | 0.0019 | 0.0632 | 0.1825 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.006 | 0.3193 | 0.3193 |
Trichomonas vaginalis | DNA helicase recq, putative | 0.0019 | 0.0632 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IZ (functional) | = 12 mm | Antibacterial activity against Escherichia coli NCIM 2666 at 100 ug/ml by agar cup plate method | ChEMBL. | 19837487 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.